Cellply
PrivateLast Round
VC Round
Apr 23, 2026
Total Funding Raised
$8.33M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cellply operates in Healthcare & Life Sciences and is based in Bologna. Its latest recorded funding round was a VC Round in September 2023.
Cellply is a biotechnology company that develops analytical tools and platforms for the characterization of cancer immunotherapies and cell therapies at single-cell resolution.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellply Comparables
Compare Cellply with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Okomera | 83% | |
| 2cureX | 82% | |
| Pear Bio | 81% |
For institutional investors. Book with your work email.
Cellply Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 23, 2026 | ||||
| VC Round | Sep 27, 2023 | ||||
| VC Round | Dec 14, 2021 | ||||
| Grant | Aug 2, 2018 | ||||
| Grant | May 1, 2018 | ||||
Grant | Oct 20, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cellply Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ZernikeMeta Ventures | Seed |
| Meta Ventures | VC Round |
| European Commission | Grant |
| Indaco Venture Partners SGR | VC Round |
| Rearden | VC Round |
| CDP Venture Capital SGR | VC Round |
| LIFTT EuroInvest | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 8504% MoM, from 46 to 4K.
- Apr 23, 2026
$8.4M raised with ENEA-Tech and CDP Venture Capital.
For institutional investors. Book with your work email.
Cellply Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellply's valuation, stock price, and market status.
Is Cellply a public or private company?
Cellply is a private company.
What is the current stock price of Cellply?
Cellply is a private company, so its shares have no public market price. Caplight tracks Cellply's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellply worth (valuation)?
Valuation information for Cellply is not publicly available.
Can I buy Cellply stock?
Cellply shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellply's last funding round?
Cellply's most recent funding round was VC Round on April 23, 2026.
Who are the main investors in Cellply?
Key investors in Cellply include European Commission, LIFTT EuroInvest, ENEA-Tech and Biomedical Foundation.
Will Cellply IPO soon?
No public IPO plans have been announced for Cellply.
How can I track Cellply secondary market activity?
Caplight tracks bids, offers, and trades in Cellply's shares on secondary markets.